Ionis Pharmaceuticals, Inc. · NASDAQ:IONS

T. Rowe Price Investment Management, Inc.'s stake in Ionis Pharmaceuticals, Inc. fell to 3.70% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

T. Rowe Price Investment Management, Inc.'s stake in Ionis Pharmaceuticals, Inc. fell to 3.70%, 6,159,027 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
3.70%
Shares
6,159,027
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.3.70%6,159,027

Source

View original at SEC

Related